— Know what they know.
Not Investment Advice

CELC NASDAQ

Celcuity Inc.
1W: +5.8% 1M: +16.4% 3M: +36.0% YTD: +41.8% 1Y: +1238.3% 3Y: +1344.1% 5Y: +429.6%
$138.23
-4.30 (-3.02%)
 
Weekly Expected Move ±12.0%
$105 $121 $138 $154 $171
NASDAQ · Healthcare · Biotechnology · Alpha Radar Strong Buy · Power 66 · $6.7B mcap · 27M float · 3.34% daily turnover · Short 67% of daily vol

Cash Flow Trends

Operating Cash Flow
-$153M -83.6% ▼
Capital Expenditures
$249K +0.4% ▲
5Y CAGR: +22.7%
Free Cash Flow
-$154M -83.4% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$143M +1857.4% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$30M-$40M-$64M-$112M-$177M
Depreciation & Amort.$303K$211K$143K$130K$167K
Stock-Based Comp.$3M$5M$5M$7M$21M
Change in Working Capital$820K-$1M$4M$18M-$3M
Other Non-Cash Items$6M$705K$1M$3M$5M
Operating Cash Flow-$20M-$36M-$54M-$83M-$153M
— Investing Activities —
Capital Expenditures-$82K-$159K-$98K-$250K-$249K
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0-$144M-$315M-$705M-$396M
Investment Sales$0$0$310M$642M$333M
Other Investing$500$0$0$0$0
Investing Cash Flow-$81K-$144M-$5M-$63M-$64M
— Financing Activities —
Net Debt Issuance$14M$20M-$2K$59M$223M
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$148K$324K$50M$16M-$46K
Financing Cash Flow$93M$120M$65M$138M$361M
Net Change in Cash$73M-$60M$6M-$8M$143M
Cash End of Period$84M$25M$31M$23M$166M
Free Cash Flow-$20M-$36M-$54M-$84M-$154M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms